Cap-assisted endoscopic sclerotherapy for treating internal hemorrhoids and rectal prolapse
Official title: Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse: a National Multi-centre Prospective Cohort Study
Run by The Second Hospital of Nanjing Medical University · NCT04169152 · Data updated 2026-11-12
This study is testing a new method using a special cap during sclerotherapy to see if it can safely and effectively treat people with internal hemorrhoids and rectal prolapse.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | The Second Hospital of Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | December 30, 2019 |
| Main results expected | December 30, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | April 2, 2024 |
| Trial ID | NCT04169152 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with Grade I-III internal hemorrhoids or rectal prolapse who have undergone bowel preparation.
✕Probably not a fit
Patients with severe complications such as acute thrombotic hemorrhoids, inflammatory bowel disease, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the efficacy and safety of cap-assisted endoscopic sclerotherapy (CAES) for patients with internal hemorrhoids and rectal prolapse. The innovative procedure utilizes a cap on the colonoscope to enhance visibility and precision during treatment, allowing for accurate injections while minimizing patient discomfort and potential complications. The study aims to gather large-scale data to confirm the long-term effectiveness of CAES, building on promising pilot results that showed sustained clinical efficacy within three months and no severe complications. By conducting this nationwide multi-center study, researchers hope to provide reliable evidence for the broader adoption of this minimally invasive technique.
Why it matters
Potential benefit: If successful, this approach could offer a safer and more effective treatment option for patients suffering from internal hemorrhoids and rectal prolapse.
How similar studies have gone: While pilot studies have shown promising results for CAES, this nationwide study aims to confirm its long-term efficacy and safety, making it a significant step in evaluating this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Grade I-III internal hemorrhoids (with or without external hemorrhoids) or/and recal prolapse. 2. Patients with bowel preparation. Exclusion Criteria: 1. History of anoscopic/endoscopic sclerotherapy. 2. Acute thrombotic hemorrhoids or grade IV internal hemorrhoids. 3. Anal stenosis, perianal and perirectal abscess, anal fissure, fistula, fecal incontinence and other severe complications (such as severe anal pain). 4. Inflammatory bowel disease. 5. Full-thickness rectal prolapse through the anus. 6. Acute diarrhea in the past 24 hours. 7. Hypertensive with uncontrolled blood pressure. 8. Cerebrovascular accident. 9. Blood coagulation dysfunction. 10. Pregnant women. 11. Mental disorders. 12. Decompensated cirrhosis.
Where it's running
-
Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Faming Zhang, MD,PhD
- Email: fzhang@njmu.edu.cn
- Phone: 02558509884
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hemorrhoid Artery Embolization (HAE) for Bleeding Internal Hemorrhoids: A Real-World Registry
This registry collects real-world data to see if hemorrhoid artery embolization helps adults with symptomatic internal hemorrhoids that haven’t improved with standard care.
-
Evaluation of a new robotic surgical system for major gastrointestinal and urologic surgeries
This study is testing a new robotic surgery system to see if it can safely and effectively help patients with major gastrointestinal and urologic conditions like colorectal and prostate cancer.
-
Evaluating the effects of rectal artery embolization for bleeding hemorrhoids
This study is testing if a procedure called rectal artery embolization can help adults with bleeding hemorrhoids feel better and improve their quality of life.
-
Registry for patients undergoing ventral mesh rectopexy for pelvic organ prolapse
This study is collecting information from patients with pelvic organ prolapse who are having a specific type of surgery to see how well it works and what problems might come up later.
-
Evaluating a new single port robotic approach for colorectal surgery
This study is testing a new single port robotic surgery method for colorectal procedures to see if it's safer and works better than the traditional multi-port approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.